TY - JOUR
T1 - Secretory Cells Are the Primary Source of pIgR in Small Airways
AU - Blackburn, Jessica B.
AU - Schaff, Jacob A.
AU - Gutor, Sergey
AU - Du, Rui Hong
AU - Nichols, David
AU - Sherrill, Taylor
AU - Gutierrez, Austin J.
AU - Xin, Matthew K.
AU - Wickersham, Nancy
AU - Zhang, Yong
AU - Holtzman, Michael J.
AU - Ware, Lorraine B.
AU - Banovich, Nicholas E.
AU - Kropski, Jonathan A.
AU - Blackwell, Timothy S.
AU - Richmond, Bradley W.
N1 - Funding Information:
Supported by Department of Veterans Affairs grant IK2BX003841 (B.W.R.), grant T32 5HL094296 (J.B.B., principal investigator T.S.B.), National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) grant K08 HL138008 (B.W.R.), Department of Veterans Affairs grant I01BX002378 (T.S.B.), NIH/National Institute of Allergy and Infectious Diseases grant R01 AI130591, NIH/NHLBI grant R35 HL145242 (M.J.H.), NIH grant HL126176 (L.B.W.), NIH/NHLBI grant R01HL145372 (J.A.K./N.E.B.), NHLBI grant K08HL130595 (J.A.K.), and the Doris Duke Charitable Foundation (J.A.K.). The authors thank Angela Jones and Neha Joshi in the Vanderbilt Technologies for Advanced Genomics Core for assistance with scRNA-seq. In addition, the authors thank the Vanderbilt Lung Transplant Team and the Vanderbilt Department of Surgical Pathology for assistance obtaining lung explants and the donors, patients, and their families who contributed invaluably to this research.
Funding Information:
Supported by Department of Veterans Affairs grant IK2BX003841 (B.W.R.), grant T32 5HL094296 (J.B.B., principal investigator T.S.B.), National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) grant K08 HL138008 (B.W.R.), Department of Veterans Affairs grant I01BX002378 (T.S.B.), NIH/National Institute of Allergy and Infectious Diseases grant R01 AI130591, NIH/NHLBI grant R35 HL145242 (M.J.H.), NIH grant HL126176 (L.B.W.), NIH/NHLBI grant R01HL145372 (J.A.K./N.E.B.), NHLBI grant K08HL130595 (J.A.K.), and the Doris Duke Charitable Foundation (J.A.K.).
Publisher Copyright:
Copyright © 2022 by the American Thoracic Society.
PY - 2022/9
Y1 - 2022/9
N2 - Loss of secretory IgA (SIgA) is common in chronic obstructive pulmonary disease (COPD) small airways and likely contributes to disease progression. We hypothesized that loss of SIgA results from reduced expression of pIgR (polymeric immunoglobulin receptor), a chaperone protein needed for SIgA transcytosis, in the COPD small airway epithelium. pIgR-expressing cells were defined and quantified at single-cell resolution in human airways using RNA in situ hybridization, immunostaining, and single-cell RNA sequencing. Complementary studies in mice used immunostaining, primary murine tracheal epithelial cell culture, and transgenic mice with secretory or ciliated cell–specific knockout of pIgR. SIgA degradation by human neutrophil elastase or secreted bacterial proteases from nontypeable Haemophilus influenzae was evaluated in vitro. We found that secretory cells are the predominant cell type responsible for pIgR expression in human and murine airways. Loss of SIgA in small airways was not associated with a reduction in secretory cells but rather a reduction in pIgR protein expression despite intact PIGR mRNA expression. Neutrophil elastase and nontypeable H. influenzae–secreted proteases are both capable of degrading SIgA in vitro and may also contribute to a deficient SIgA immunobarrier in COPD. Loss of the SIgA immunobarrier in small airways of patients with severe COPD is complex and likely results from both pIgR-dependent defects in IgA transcytosis and SIgA degradation.
AB - Loss of secretory IgA (SIgA) is common in chronic obstructive pulmonary disease (COPD) small airways and likely contributes to disease progression. We hypothesized that loss of SIgA results from reduced expression of pIgR (polymeric immunoglobulin receptor), a chaperone protein needed for SIgA transcytosis, in the COPD small airway epithelium. pIgR-expressing cells were defined and quantified at single-cell resolution in human airways using RNA in situ hybridization, immunostaining, and single-cell RNA sequencing. Complementary studies in mice used immunostaining, primary murine tracheal epithelial cell culture, and transgenic mice with secretory or ciliated cell–specific knockout of pIgR. SIgA degradation by human neutrophil elastase or secreted bacterial proteases from nontypeable Haemophilus influenzae was evaluated in vitro. We found that secretory cells are the predominant cell type responsible for pIgR expression in human and murine airways. Loss of SIgA in small airways was not associated with a reduction in secretory cells but rather a reduction in pIgR protein expression despite intact PIGR mRNA expression. Neutrophil elastase and nontypeable H. influenzae–secreted proteases are both capable of degrading SIgA in vitro and may also contribute to a deficient SIgA immunobarrier in COPD. Loss of the SIgA immunobarrier in small airways of patients with severe COPD is complex and likely results from both pIgR-dependent defects in IgA transcytosis and SIgA degradation.
KW - airway epithelium
KW - chronic obstructive pulmonary disease
KW - secretory IgA
KW - secretory cells
UR - http://www.scopus.com/inward/record.url?scp=85137137795&partnerID=8YFLogxK
U2 - 10.1165/rcmb.2021-0548OC
DO - 10.1165/rcmb.2021-0548OC
M3 - Article
C2 - 35687143
AN - SCOPUS:85137137795
SN - 1044-1549
VL - 67
SP - 334
EP - 345
JO - American journal of respiratory cell and molecular biology
JF - American journal of respiratory cell and molecular biology
IS - 3
ER -